Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CKD-342 in perennial allergic rhinitis
NCT02498509Phase 3Completed
- Sponsor
- Chong Kun Dang Holdings
- Start
- May 2015
- Primary completion
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of mometasone furoate + levocabastine hcl in perennial allergic rhinitis (PAR), sponsored by Chong Kun Dang Holdings. Started May 2015; status: completed.
02
Drugs
mometasone furoate + levocabastine hcl
03
Conditions
perennial allergic rhinitis (PAR)
Beyond the preview
Go deeper on NCT02498509.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02498509.